Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | - <10,4;Cleavage;R1>
- <10,H;Oxidation;R1>
- <14,H;Hydroxylation;R2>
- <15,H;Hydroxylation;R3>
| | | | | | - <10,4;Cleavage;R1>
- <10,H;Oxidation;R1>
- <14,H;Hydroxylation;R2>
- <15,H;Hydroxylation;R3>
| | |
|
---|
References | - Rowland K, Ellis SW, Lennard MS, Tucker GT: Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propranolol by human liver microsomes. Br J Clin Pharmacol. 1996 Sep;42(3):390-3. doi: 10.1046/j.1365-2125.1996.43116.x. [PubMed:8877032 ]
- Ching MS, Bichara N, Blake CL, Ghabrial H, Tukey RH, Smallwood RA: Propranolol 4- and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P4501A1 and P4501A2. Drug Metab Dispos. 1996 Jun;24(6):692-4. [PubMed:8781788 ]
- Mankowski DC: The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6. Drug Metab Dispos. 1999 Sep;27(9):1024-8. [PubMed:10460802 ]
- Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T: Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol. 1995 Apr;39(4):421-31. doi: 10.1111/j.1365-2125.1995.tb04472.x. [PubMed:7640150 ]
|
---|